Alphatec Holdings, Inc.
General ticker "ATEC" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $2.1B (TTM average)
Alphatec Holdings, Inc. does not follow the US Stock Market performance with the rate: -24.6%.
Estimated limits based on current volatility of 3.0%: low 10.48$, high 11.14$
Factors to consider:
- Earnings expected soon, date: 2026-10-29 amc
- Total employees count: 913 (+5.3%) as of 2025
- US accounted for 93.7% of revenue in the fiscal year ended 2025-12-31
- Top business risk factors: Market competition, Regulatory and compliance, Product recalls, Key person loss, Supply chain disruptions
- Current price 28.7% below estimated low
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [14.67$, 30.18$]
- 2026-12-31 to 2027-12-31 estimated range: [13.22$, 27.61$]
Financial Metrics affecting the ATEC estimates:
- Positive: with PPE of -174.2 at the end of fiscal year the price was neutral
- Negative: Operating cash flow per share per price, % of 1.44 <= 2.37
- Positive: -13.52 < Operating profit margin, % of -9.70
- Negative: negative Net income
- Negative: Shareholder equity ratio, % of 4.55 <= 7.04
- Negative: negative Industry operating cash flow (median)
- Negative: negative Industry operating income (median)
- Negative: 0.47 < Industry inventory ratio change (median), % of 0.70
- Positive: Interest expense per share per price, % of 0.67 <= 0.75
- Negative: Industry earnings per price (median), % of -3.46 <= 0
Short-term ATEC quotes
Long-term ATEC plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $482.26MM | $611.56MM | $764.15MM |
| Operating Expenses | $655.66MM | $747.73MM | $846.28MM |
| Operating Income | $-173.40MM | $-136.17MM | $-82.13MM |
| Non-Operating Income | $-13.52MM | $-25.90MM | $-61.27MM |
| Interest Expense | $16.64MM | $24.88MM | $21.14MM |
| R&D Expense | $70.11MM | $80.72MM | $76.27MM |
| Income(Loss) | $-186.91MM | $-162.07MM | $-143.40MM |
| Taxes | $-0.28MM | $0.05MM | $-0.04MM |
| Net Income(Loss)* | $-186.64MM | $-162.12MM | $-143.36MM |
| Stockholders Equity | $101.72MM | $9.43MM | $36.03MM |
| Inventory | $136.84MM | $175.26MM | $169.44MM |
| Assets | $805.21MM | $775.71MM | $791.21MM |
| Operating Cash Flow | $-78.48MM | $-44.65MM | $45.23MM |
| Capital expenditure | $86.97MM | $93.14MM | $42.45MM |
| Investing Cash Flow | $-141.97MM | $-93.14MM | $-53.41MM |
| Financing Cash Flow | $356.92MM | $56.21MM | $30.02MM |
| Earnings Per Share** | $-1.54 | $-1.13 | $-0.96 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.